Investigators assessed the impact of human milk oligosaccharides on the intestinal microbiota of children, as well as their safety profile and digestive tolerance.
Investigators compared the safety and efficacy profiles of BI 695501 and adalimumab reference product in patients with moderately to severely active Crohn disease.
Researchers assessed whether depression in the presence or absence of previous GI symptoms is associated with a future diagnosis of IBD.
For patients with alcohol-related liver disease who require transplantation, there is mixed evidence supporting the requirement that patients abstain from alcohol consumption for 6 months prior to transplantation.
Investigators assessed the factors associated with medication treatment for opioid use disorder and whether it is linked to hepatic decompensation or death in patients with cirrhosis and active opioid use disorder.
Based on a mathematical model, investigators evaluated improvements to the care cascade for people with hepatitis C virus who inject drugs.
Investigators assessed the efficacy of sequential scheduling of bevacizumab in combination with chemotherapy to improve outcomes in patients with metastatic colorectal cancer.
Researchers aimed to assess the safety and efficacy of fatty acid synthase inhibitor TVB-2640 on liver fat and biomarkers for liver and metabolic health in patients with NASH.
Investigators aimed to determine the association between maternal gestational elevated serum total bile acid concentrations and the risk for intrauterine growth restrictions.
Investigators aimed to determine whether a higher number of psychological comorbidities at baseline would exacerbate IBS prognosis in patients with Rome IV-defined IBS.
